7th In-House Impact: Biopharma Summit 2027

The 7th In-House Impact: Biopharma Summit is an annual event tailored for senior in-house legal leaders, including General Counsels and Chief Legal Officers, from early, growth, and commercial-stage biopharmaceutical companies. Organized by Hanson Wade, this summit provides a dedicated platform for navigating the complexities of the biopharma industry, such as evolving FDA expectations, pricing reforms, geopolitical shifts, and the integration of AI into legal operations. The 2027 edition is scheduled for August 5–6, 2027, at The Colonnade Hotel in Boston, Massachusetts.

The summit's agenda focuses on critical topics pertinent to the biopharma sector. Sessions cover strategies for managing FDA policy shifts, preparing for pricing reforms, designing responsible AI governance frameworks, safeguarding intellectual property and trade secrets, strengthening compliance maturity, anticipating cross-border risks, and improving deal readiness for partnerships, mergers and acquisitions, and IPO preparations. These discussions are led by over 18 senior legal leaders from organizations such as Olema Oncology, Caribou Biosciences, Enveda Biosciences, Takeda Oncology, Legend Biotech, Boundless Bio, and Sionna Therapeutics.

Attendees can expect more than eight hours of dedicated networking opportunities, including speed networking sessions and roundtable discussions, facilitating meaningful exchanges among peers. Notable speakers include Shawnte Mitchell, Chief Legal Officer & Corporate Secretary at Olema Oncology, and Jason Tejani, General Counsel & Corporate Secretary at Enveda Therapeutics, Inc. The event will be held at The Colonnade Hotel in Boston, Massachusetts, providing a conducive environment for learning and collaboration.

This summit is ideal for General Counsels, Chief Legal Officers, and senior in-house legal professionals within early-stage, growth-stage, and commercial biopharma organizations. It offers a unique opportunity to benchmark with peers, gain candid insights, and acquire practical strategies to address the pressing legal challenges of 2026.